Načítá se...
SUN-323 Somatostatin Analogue: An Effective Treatment for Pseudoglucagonoma Syndrome
INTRODUCTION: Pseudoglucagonoma syndrome (PS) refers to the presence of necrolytic migratory erythema (NME), despite normal glucagon levels, and absence of a glucagon-secreting tumor. We present a case of PS successfully treated with octreotide. CASE PRESENTATION: A 42-year-old woman with history of...
Uloženo v:
| Vydáno v: | J Endocr Soc |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Endocrine Society
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552871/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-323 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|